UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Recurrence of membranoproliferative glomerulonephritis type II in renal allografts : The North American Pediatric Renal Transplant Cooperative Study experience

Journal of the American Society of Nephrology, 2005-07, Vol.16 (7), p.2225-2233

2005

Volltextzugriff (PDF)

Study 2: evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the National Institutes of Health IG02 trial

Transplantation reviews (Philadelphia, Pa.), 2003-10, Vol.17 (4), p.S34-S34

2003

Volltextzugriff (PDF)

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

The Lancet (British edition), 2018-01, Vol.391 (10118), p.309-318

2018

Volltextzugriff (PDF)

Component‐resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness

Allergy (Copenhagen), 2016-11, Vol.71 (11), p.1552-1560

2016

Volltextzugriff (PDF)

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls

AIDS (London), 2016-01, Vol.30 (3), p.435-444

2016

Volltextzugriff (PDF)

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

The New England journal of medicine, 2016-06, Vol.374 (22), p.2120-2130

2016

Volltextzugriff (PDF)

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Contemporary clinical trials, 2016-09, Vol.50, p.253-264

2016

Volltextzugriff (PDF)

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity

PloS one, 2010-08, Vol.5 (8), p.e11995

2010

Volltextzugriff (PDF)

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope

The Journal of immunology (1950), 2012-05, Vol.188 (10), p.5166-5176

2012

Volltextzugriff (PDF)

Egg-Specific IgA and IgA2 Are Associated with Sustained Unresponsiveness to Egg Following Oral Immunotherapy

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB38-AB38

2015

Volltextzugriff (PDF)

2008 Update from the Collaborative Islet Transplant Registry

Transplantation, 2008-12, Vol.86 (12), p.1783

2008

Volltextzugriff (PDF)

Risk behaviour and time as covariates for effi cacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 effi cacy trial RV 144

The Lancet infectious diseases, 2012-07, Vol.12 (7), p.531

2012

Volltextzugriff (PDF)

Ad hoc analysis of behavior and time as co-variates of the Thai phase III efficacy trial: RV 144

The Lancet infectious diseases, 2012-05, Vol.12 (7), p.531-537

2012

Volltextzugriff (PDF)

Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

The Journal of infectious diseases, 1998-05, Vol.177 (5), p.1230-1246

1998

Volltextzugriff (PDF)

MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates

AIDS research and human retroviruses, 1999-07, Vol.15 (10), p.921-930

1999

Volltextzugriff (PDF)

Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing$HIV-1_mn$gpl20,$HIV-1_SF2$Recombinant gp120, or Both Vaccines in Seronegative Adults

The Journal of infectious diseases, 1998-05, Vol.177 (5), p.1230-1246

1998

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Humans
(10)
Life Sciences & Biomedicine
(10)
Female
(8)
Male
(8)
Adult
(6)
Biological And Medical Sciences
(5)
Immunology
(5)
Infectious Diseases
(5)
Adolescent
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Hiv
(3)
Human Immunodeficiency Virus
(3)
Human Immunodeficiency Virus 1
(3)
Medical Sciences
(3)
Middle Aged
(3)
Virology
(3)
Administration, Oral
(2)
Aids
(2)
Antibodies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recurrence of membranoproliferative glomerulonephritis type II in renal allografts : The North American Pediatric Renal Transplant Cooperative Study experience

Study 2: evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the National Institutes of Health IG02 trial

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Component‐resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope

Egg-Specific IgA and IgA2 Are Associated with Sustained Unresponsiveness to Egg Following Oral Immunotherapy

2008 Update from the Collaborative Islet Transplant Registry

Risk behaviour and time as covariates for effi cacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 effi cacy trial RV 144

Ad hoc analysis of behavior and time as co-variates of the Thai phase III efficacy trial: RV 144

Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates

Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1 Mn gp120, HIV‐1 SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing$HIV-1_mn$gpl20,$HIV-1_SF2$Recombinant gp120, or Both Vaccines in Seronegative Adults

Suchergebnisse filtern